Estonia vs Oman: HIV-positive TB patients on ART (antiretroviral therapy)
Estonia
100.0%
in 2024
Oman
100.0%
in 2024
Estonia rank
1st
Oman rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Estonia
- Oman
How they compare
Estonia currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 6 times across 17 shared years of data; in 2008 it was Oman ahead.
Estonia ranks 1st and Oman ranks 1st of 144 countries.
Across the 3 decades both report, Estonia averaged higher in 1 and Oman in 2.
Head to head by decade
| Decade | Estonia | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.5% | 100.0% | 54.5% | Oman |
| 2010s | 76.8% | 93.1% | 16.3% | Oman |
| 2020s | 93.2% | 91.4% | 1.8% | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Estonia or Oman?
- Estonia, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Estonia and Oman?
- 0.0%, with Estonia ahead.
- How many years of comparable data are there for Estonia and Oman?
- 17 years are reported by both, from 2008 to 2024.
- How do Estonia and Oman rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Estonia ranks 1st and Oman ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.